InsidersTradesSigma
Track the 赛科希德 share price and the full directors' dealings record of the company, a listed equity based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 赛科希德 has recorded 20 insider filings. Market capitalisation: €2.8bn. The latest transaction was filed on 23 July 2025 (Sale). Among the most active insiders: 于松岩. The full history is free.
20
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€4m
20 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,872 of 28,892 companies
59.4
score / 100
Value40
Quality79
FCF yld1.6%
Earn yld3.2%
EV/EBITDA24.0x
ROE5.1%
Gross mgn62%
Net mgn34%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 July 2025
Declarations20 total
20 of 20 declarations
About 赛科希德
赛科希德 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHG market. It specializes in the development and marketing of pharmaceutical products.